等待開盤 08-22 09:30:00 美东时间
+0.020
+0.10%
Records from August 13, 2025 indicate that Representative George Whitesides of ...
08-14 23:00
During the last three months, 4 analysts shared their evaluations of Innoviva (...
08-12 02:01
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Innoviva (NASDAQ:INVA) with a Buy and raises the price target from $40 to $45.
08-11 18:41
Harrow (NASDAQ:HROW) will release its quarterly earnings report on Monday, 2025...
08-08 23:05
①今日举行的业绩会中,再鼎医药管理层对部分主要产品销售情况以及下半年业绩展望做出了介绍; ②再鼎医药还就鼎优乐药物短缺问题,以及肿瘤类、精神类药物管线进展和商业化布局等问题做出了回应。
08-08 16:02
Innoviva (NASDAQ:INVA) reported quarterly earnings of $0.77 per share which beat the analyst consensus estimate of $0.49 by 57.14 percent. This is a 240 percent increase over losses of $(0.55) per share from the same
08-07 05:12
WAVE Life Sciences (NASDAQ:WVE) is preparing to release its quarterly earnings ...
07-30 05:01
据一位知情人士透露,美国食品药品监督管理局(FDA)局长马蒂·马卡里已选定前生物技术高管乔治·蒂德马什担任该局首席药品监管官。
07-21 20:34
Cantor Fitzgerald analyst Steve Seedhouse initiates coverage on Innoviva (NASDAQ:INVA) with a Overweight rating and announces Price Target of $26.
07-11 20:04
https://register.epo.org/application?number=EP21793606
07-09 03:58